Page 372 - medicina-integrativa_compress

CAPÍTULO 34 SÍNDROME DE SENSIBILIDAD A MÚLTIPLES SUSTANCIAS QUÍMICAS 371

12 meses) para que aparezcan los ■ Procedimientos de desintoxicación
beneficios, a menos que predominen los
riesgos. • Hay que condiderar la remisión para
tratamiento de quelación oral en caso de
C 2 2
una carga orgánica documentada de
metales pesados.
■ Técnicas de manipulación terapéutica
• El masaje, la osteopatía y la quiropraxia • Hay que considerar remitir al paciente
son complementos de utilidad, sobre todo para desintoxicación en sauna con apoyo
C 1
en pacientes con manifestaciones apropiado de electrolitos y nutrientes
musculoesqueléticas de intolerancias durante los procedimientos.
ambientales. Se evitará el empleo
concomitante de lociones y aceites
perfumados. ■ Fármacos

• Se minimiza el uso de fármacos: los
pacientes calificaron la mayor parte de las
■ Complementos nutricionales C 2 2
y fitosuplementos intervenciones psicofarmacológicas
(antidepresivos, ansiolíticos) como más
• Los pacientes comunican buenos cocientes perjudiciales que beneficiosas, pero para
beneficio/perjuicio con bacilo acidophilus, algunos, la nistatina o el fluconazol para la
C 2 2
magnesio, vitaminas C y E (supuestamente supuesta infección sistémica por
tocoferoles mixtos, pero no hay datos) y Candida/levaduras resultaron más
semilla de cardo mariano. Se comienza beneficiosos que dañinos. Se comienza con
con un programa de dosificación geriática un programa de dosis geriátrica (de un
(de un cuarto a la mitad de la dosis usual cuarto a la mitad de la dosis usual en el
en el adulto). adulto).

BIBLIOGRAFÍA 15. Bell IR, Peterson JM, Schwartz GE: Medical histories and
psychological profiles of middle-aged women with and without
1. Miller CS: The compelling anomaly of chemical intolerance. Ann N self-reported illness from environmental chemicals. J Clin
Y Acad Sci 933:1-23, 2001. Psychiatry 56:151-160, 1995.
2. Fiedler N, Kipen HM, DeLuca J, et al: A controlled comparison of 16. Black DW, Okiishi C, Gabel J, Schlosser S: Psychiatric illness in the
multiple chemical sensitivities and chronic fatigue syndrome. first-degree relatives of persons reporting multiple chemical
Psychosom Med 58:38-49, 1996. sensitivities. Toxicol Ind Health 15:410-414, 1999.
3. Miller CS, Mitzel HC: Chemical sensitivity attributed to pesticide 17. Baldwin CM, Bell IR: Increased cardiopulmonary disease risk
exposure versus remodeling. Arch Environ Health 50:119-129, 1995. in a community-based sample with chemical odor intolerance:
4. Bell IR, Baldwin CM, Fernandez M, Schwartz GE: Neural Implications for women’s health and health-care utilization.
sensitization model for multiple chemical sensitivity: Overview of Arch Environ Health 53:347-353, 1998.
theory and empirical evidence. Toxicol Ind Health 15:295-304, 1999. 18. Caress SM, Steinemann AC: A national population study of the
5. Sorg BA, Tschirgi ML, Swindell S, et al: Repeated formaldehyde prevalence of multiple chemical sensitivity. Arch Environ Health
effects in an animal model for multiple chemical sensitivity. Ann N 59:300-305, 2004.
Y Acad Sci 933:57-67, 2001. 19. Bell IR, Schwartz GE, Peterson JM, et al: Possible time-dependent
6. Meggs WJ: Mechanisms of allergy and chemical sensitivity. Toxicol sensitization to xenobiotics: Self-reported illness from chemical
© Elsevier. Es una publicación MASSON. Fotocopiar sin autorización es un delito.
Ind Health 15:331-338, 1999. odors, foods, and opiate drugs in an older adult population. Arch
7. Pall ML: NMDA sensitization and stimulation by peroxynitrite, Environ Health 48:315-327, 1993.
nitric oxide, and organic solvents as the mechanism of chemical 20. Bell IR, Miller CS, Schwartz GE, et al: Neuropsychiatric and somatic
sensitivity in multiple chemical sensitivity. FASEB Jo 16:1407-1417, characteristics of young adults with and without self-reported
2002. chemical odor intolerance and chemical sensitivity. Arch Environ
8. Devriese S, Winters W, Van Diest I, et al: Perceived relation between Health 51:9-21, 1996.
odors and a negative event determines learning of symptoms in 21. Ciccone DS, Natelson BH: Comorbid illness in women with chronic
response to chemicals. Int Arch Occup Environ Health 77:200-204, fatigue syndrome: A test of the single syndrome hypothesis.
2004. Psychosom Med 65:268-275, 2003.
9. Van den Bergh O, Devriese S, Winters W, et al: Acquiring symptoms 22. Binkley K, King N, Poonai N, et al: Idiopathic environmental
in response to odors: A learning perspective on multiple chemical intolerance: Increased prevalence of panic disorder-associated
sensitivity. Ann N Y Acad Sci 933:278-290, 2001. cholecystokinin B receptor allele 7. J Allergy Clin Immunol
10. Cloutier S, Forquer MR, Sorg BA: Low level lindane exposure alters 107:887-890, 2001.
extinction of conditioned fear in rats. Toxicology 217:147-154, 2006. 23. McKeown-Eyssen GE, Baines C, et al: Case-control study of
11. Sorg BA, Swindell S, Tschirgi ML: Repeated low level formaldehyde genotypes in multiple chemical sensitivity: CYP2D6, NAT1, NAT2,
exposure produces enhanced fear conditioning to odor in male, but PON1, PON2, and MTHFR. Int J Epidemiol 33:1-8, 2004.
not female, rats. Brain Res 1:11-19, 2004. 24. Bell IR: Somatization disorder: Health care costs in the decade of the
12. Randolph T: Specific adaptation. Ann Allergy 40:333-345, 1978. brain. Biol Psychiatry 35:81-83, 1994.
13. Atkinson W, Sheldon TA, Shaath N, Whorwell PJ: Food elimination 25. Antelman SM, Caggiula AR, Kiss S, et al: Neurochemical and
based on IgG antibodies in irritable bowel syndrome: A randomised physiological effects of cocaine oscillate with sequential drug
controlled trial. Gut 53:1459-1464, 2004. treatment: Possibly a major factor in drug variability.
14. Aaron LA, Buchwald D: Chronic diffuse musculoskeletal pain, Neuropsychopharmacology 12:297-306, 1995.
fibromyalgia and co-morbid unexplained clinical conditions. Best 26. Gibson PR, Elms ANM, Ruding LA: Perceived treatment efficacy
Pract Res Clin Rheumatol 17:563-574, 2003. for conventional and alternative therapies reported by persons